Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980857560> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2980857560 endingPage "444" @default.
- W2980857560 startingPage "437" @default.
- W2980857560 abstract "The aim of the JUST-ACT study was to assess whether the add-on effect of tocilizumab (TCZ) to background methotrexate (MTX) observed in MTX-inadequate responders with active rheumatoid arthritis (RA), would be sustained when MTX is withdrawn.A double-blind, parallel-group, phase 3 study in biologic-naïve RA patients with a disease activity score 28 (DAS28)>3.2 despite MTX which were treated with TCZ+MTX for an initial 16-week period. Patients who at week 16 achieved low disease activity (LDA) (DAS28≤3.2) were randomised to continue with TCZ+MTX or switch to TCZ + placebo (PBO) for an additional 12 weeks. The primary endpoint was the change in DAS28-ESR from the randomisation at week 16 to week 28. Non-inferiority was confirmed if the upper limit of the two-sided 95%CI for the treatment difference between TCZ+MTX and TCZ monotherapy groups was lower than the selected non-inferiority margin of 0.6.261 patients completed the first 16 weeks of TCZ+MTX treatment and 165 were randomised (83 to TCZ+MTX and 82 to TCZ+PBO). For the primary endpoint, the adjusted treatment difference (95% CI) in mean change of DAS28-ESR was -0.06 (-0.40 to 0.27), and therefore the non-inferiority of switching to TCZ monotherapy versus continuing with TCZ+MTX was demonstrated. In both treatment groups, the percentage of patients in clinical remission from 16 to 28 weeks was similar as were the improvements in disease activity, functional disability and quality of life.In MTX non-responder patients achieving LDA with TCZ+MTX, switching to TCZ monotherapy is non-inferior to continuing the combination." @default.
- W2980857560 created "2019-10-25" @default.
- W2980857560 creator A5005291921 @default.
- W2980857560 creator A5008549027 @default.
- W2980857560 creator A5008838256 @default.
- W2980857560 creator A5019811024 @default.
- W2980857560 creator A5028461558 @default.
- W2980857560 creator A5029195692 @default.
- W2980857560 creator A5035117024 @default.
- W2980857560 creator A5058897535 @default.
- W2980857560 creator A5065352512 @default.
- W2980857560 creator A5090895656 @default.
- W2980857560 date "2018-10-10" @default.
- W2980857560 modified "2023-10-03" @default.
- W2980857560 title "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study." @default.
- W2980857560 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30299241" @default.
- W2980857560 hasPublicationYear "2018" @default.
- W2980857560 type Work @default.
- W2980857560 sameAs 2980857560 @default.
- W2980857560 citedByCount "4" @default.
- W2980857560 countsByYear W29808575602020 @default.
- W2980857560 countsByYear W29808575602022 @default.
- W2980857560 crossrefType "journal-article" @default.
- W2980857560 hasAuthorship W2980857560A5005291921 @default.
- W2980857560 hasAuthorship W2980857560A5008549027 @default.
- W2980857560 hasAuthorship W2980857560A5008838256 @default.
- W2980857560 hasAuthorship W2980857560A5019811024 @default.
- W2980857560 hasAuthorship W2980857560A5028461558 @default.
- W2980857560 hasAuthorship W2980857560A5029195692 @default.
- W2980857560 hasAuthorship W2980857560A5035117024 @default.
- W2980857560 hasAuthorship W2980857560A5058897535 @default.
- W2980857560 hasAuthorship W2980857560A5065352512 @default.
- W2980857560 hasAuthorship W2980857560A5090895656 @default.
- W2980857560 hasConcept C126322002 @default.
- W2980857560 hasConcept C142724271 @default.
- W2980857560 hasConcept C203092338 @default.
- W2980857560 hasConcept C204787440 @default.
- W2980857560 hasConcept C27081682 @default.
- W2980857560 hasConcept C2777077863 @default.
- W2980857560 hasConcept C2777178219 @default.
- W2980857560 hasConcept C2777575956 @default.
- W2980857560 hasConcept C2781059491 @default.
- W2980857560 hasConcept C535046627 @default.
- W2980857560 hasConcept C71924100 @default.
- W2980857560 hasConcept C90924648 @default.
- W2980857560 hasConceptScore W2980857560C126322002 @default.
- W2980857560 hasConceptScore W2980857560C142724271 @default.
- W2980857560 hasConceptScore W2980857560C203092338 @default.
- W2980857560 hasConceptScore W2980857560C204787440 @default.
- W2980857560 hasConceptScore W2980857560C27081682 @default.
- W2980857560 hasConceptScore W2980857560C2777077863 @default.
- W2980857560 hasConceptScore W2980857560C2777178219 @default.
- W2980857560 hasConceptScore W2980857560C2777575956 @default.
- W2980857560 hasConceptScore W2980857560C2781059491 @default.
- W2980857560 hasConceptScore W2980857560C535046627 @default.
- W2980857560 hasConceptScore W2980857560C71924100 @default.
- W2980857560 hasConceptScore W2980857560C90924648 @default.
- W2980857560 hasIssue "3" @default.
- W2980857560 hasLocation W29808575601 @default.
- W2980857560 hasOpenAccess W2980857560 @default.
- W2980857560 hasPrimaryLocation W29808575601 @default.
- W2980857560 hasRelatedWork W189077404 @default.
- W2980857560 hasRelatedWork W1999848283 @default.
- W2980857560 hasRelatedWork W2045253669 @default.
- W2980857560 hasRelatedWork W2053109122 @default.
- W2980857560 hasRelatedWork W2098703756 @default.
- W2980857560 hasRelatedWork W2123414080 @default.
- W2980857560 hasRelatedWork W2783466784 @default.
- W2980857560 hasRelatedWork W2970100988 @default.
- W2980857560 hasRelatedWork W3139028834 @default.
- W2980857560 hasRelatedWork W2339395249 @default.
- W2980857560 hasVolume "37" @default.
- W2980857560 isParatext "false" @default.
- W2980857560 isRetracted "false" @default.
- W2980857560 magId "2980857560" @default.
- W2980857560 workType "article" @default.